0001567619-19-006914.txt : 20190314
0001567619-19-006914.hdr.sgml : 20190314
20190314190854
ACCESSION NUMBER: 0001567619-19-006914
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190213
FILED AS OF DATE: 20190314
DATE AS OF CHANGE: 20190314
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jooss Karin
CENTRAL INDEX KEY: 0001754280
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38663
FILM NUMBER: 19682488
MAIL ADDRESS:
STREET 1: C/O GRITSTONE ONCOLOGY, INC.
STREET 2: 5858 HORTON STREET, SUITE 210
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gritstone Oncology, Inc.
CENTRAL INDEX KEY: 0001656634
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5858 HORTON STREET, SUITE 210
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (510) 871-6100
MAIL ADDRESS:
STREET 1: 5858 HORTON STREET, SUITE 210
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
4
1
doc1.xml
FORM 4
X0306
4
2019-02-13
0
0001656634
Gritstone Oncology, Inc.
GRTS
0001754280
Jooss Karin
C/O GRITSTONE ONCOLOGY, INC.
5858 HORTON STREET, SUITE 210
EMERYVILLE
CA
94608
0
1
0
0
See Remarks
Stock Option (Right to Buy)
12.02
2019-02-13
4
A
0
66000
0
A
2019-04-01
2029-02-12
Common Stock
66000
66000
D
The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on March 1, 2019.
Executive Vice President and Chief Scientific Officer
/s/ Dana B. Johnson, Attorney-in-Fact for Karin Jooss
2019-03-14